Triptolide cooperates with chemotherapy to induce apoptosis in acute myeloid leukemia cells.
D017304:Annexin A5 / Q000378:metabolism; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology* / Q000627:therapeutic use; D017209:Apoptosis / Q000187:drug effects*; D045744:Cell Line, Tumor; D003561:Cytarabine / Q000819:agonists / Q000494:pharmacology* / Q000627:therapeutic use; D004224:Diterpenes / Q000819:agonists / Q000494:pharmacology* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004354:Drug Screening Assays, Antitumor; D004357:Drug Synergism; D004852:Epoxy Compounds / Q000819:agonists / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D020672:I-kappa B Proteins / Q000378:metabolism; D015255:Idarubicin / Q000819:agonists / Q000494:pharmacology* / Q000627:therapeutic use; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000378:metabolism; D017493:Leukocyte Common Antigens / Q000378:metabolism; D010616:Phenanthrenes / Q000819:agonists / Q000494:pharmacology* / Q000627:therapeutic use; D051636:X-Linked Inhibitor of Apoptosis Protein / Q000378:metabolism
D017304:Annexin A5; D004224:Diterpenes; D004852:Epoxy Compounds; D020672:I-kappa B Proteins; D010616:Phenanthrenes; D051636:X-Linked Inhibitor of Apoptosis Protein; C496866:XIAP protein, human; D003561:Cytarabine; C001899:triptolide; D017493:Leukocyte Common Antigens; C516769:PTPRC protein, human; D015255:Idarubicin